Research uncovers how to target 'sleeping' breast cancer cells and prevent relapse

byInstitute of Cancer ResearchModel: Endocrine therapy-induced dormancy is characterized by a consistent epigenetic reprogramming involving a global increase in histone repressive marks. The dor

Updated on: March 28,2024

Research uncovers how to target 'sleeping' breast cancer cells and prevent relapse

byInstitute of Cancer ResearchModel: Endocrine therapy-induced dormancy is characterized by a consistent epigenetic reprogramming involving a global increase in histone repressive marks. The dor

Updated on:March 28,2024

New research may hold key to better treatments for aggressive brain cancer

by Spectrum HealthPrakash Chinnaiyan, M.D., a physician scientist in the Department of Radiation Oncology at Corewell Health in Southeast, Mich. Credit: Elizabeth Debeliso, Corewell HealthFor decades,

Updated on: January 13,2024

New research may hold key to better treatments for aggressive brain cancer

by Spectrum HealthPrakash Chinnaiyan, M.D., a physician scientist in the Department of Radiation Oncology at Corewell Health in Southeast, Mich. Credit: Elizabeth Debeliso, Corewell HealthFor decades,

Updated on:January 13,2024

Tumor heterogeneity and immune-evasive environment in malignant lymphoma at single-cell resolution

byUniversity of TsukubaTranscriptomic profile of T follicular helper cell lymphoma (TFHL) samples. Credit:Leukemia(2023). DOI: 10.1038/s41375-023-02093-7Researchers at the University

Updated on: January 26,2024

Tumor heterogeneity and immune-evasive environment in malignant lymphoma at single-cell resolution

byUniversity of TsukubaTranscriptomic profile of T follicular helper cell lymphoma (TFHL) samples. Credit:Leukemia(2023). DOI: 10.1038/s41375-023-02093-7Researchers at the University

Updated on:January 26,2024

Personalized simulations predict patient outcomes for blood cancer treatment in breakthrough study

byUniversity of SussexComputational modeling of the cell cycle and apoptosis reveal limited impact of archetypal double hit mutations on their respective molecular networks. Credit:Blood C

Updated on: July 17,2024

Personalized simulations predict patient outcomes for blood cancer treatment in breakthrough study

byUniversity of SussexComputational modeling of the cell cycle and apoptosis reveal limited impact of archetypal double hit mutations on their respective molecular networks. Credit:Blood C

Updated on:July 17,2024

Treating the TOTAL patient: clinical trial reduces relapse

by St. Jude Children's Research HospitalSima Jeha, M.D., of the St. Jude Departments of Oncology and Global Pediatric Medicine, and Ching-Hon Pui, M.D., chair of the St. Jude Department of On

Updated on: April 10,2024

Treating the TOTAL patient: clinical trial reduces relapse

by St. Jude Children's Research HospitalSima Jeha, M.D., of the St. Jude Departments of Oncology and Global Pediatric Medicine, and Ching-Hon Pui, M.D., chair of the St. Jude Department of On

Updated on:April 10,2024

New insights into treating a rare leukemia

by Children's Hospital Los AngelesBone marrow aspirate showing acute myeloid leukemia. Several blasts have Auer rods. Credit: WikipediaA study at Children's Hospital Los Angeles is sheddi

Updated on: April 10,2024

New insights into treating a rare leukemia

by Children's Hospital Los AngelesBone marrow aspirate showing acute myeloid leukemia. Several blasts have Auer rods. Credit: WikipediaA study at Children's Hospital Los Angeles is sheddi

Updated on:April 10,2024

International team discovers unique pathway for treating deadly children's brain cancer

by Steve Yozwiak,The Translational Genomics Research InstituteCredit: CC0 Public DomainAn international team of researchers led by Yale University, University of Iowa, and the Translational Geno

Updated on: March 12,2024

International team discovers unique pathway for treating deadly children's brain cancer

by Steve Yozwiak,The Translational Genomics Research InstituteCredit: CC0 Public DomainAn international team of researchers led by Yale University, University of Iowa, and the Translational Geno

Updated on:March 12,2024

Researchers identify new way to make cancer self-destruct

by Perelman School of Medicine at the University of PennsylvaniaATF4 is at a point after both pathways come back together. Credit: Penn MedicineFor years, researchers have been trying to target a

Updated on: June 19,2024

Researchers identify new way to make cancer self-destruct

by Perelman School of Medicine at the University of PennsylvaniaATF4 is at a point after both pathways come back together. Credit: Penn MedicineFor years, researchers have been trying to target a

Updated on:June 19,2024

New possibilities for treating intractable brain tumors unveiled

New possibilities for treating intractable brain tumors unveiledbyThe Korea Advanced Institute of Science and Technology (KAIST)Overview of the study on the enhanced response to anti-PD-1 therap

Updated on: December 01,2024

New possibilities for treating intractable brain tumors unveiled

New possibilities for treating intractable brain tumors unveiledbyThe Korea Advanced Institute of Science and Technology (KAIST)Overview of the study on the enhanced response to anti-PD-1 therap

Updated on:December 01,2024

Drug that targets scar-like tissue in tumors shows promise for aggressive pancreatic cancer

by Garvan Institute of Medical ResearchThe new drug, PXS-5505, breaking down the fibrotic tissue around pancreatic cancer cells. Credit: Ella MaruFindings from the Garvan Institute of Medical Res

Updated on: February 20,2024

Drug that targets scar-like tissue in tumors shows promise for aggressive pancreatic cancer

by Garvan Institute of Medical ResearchThe new drug, PXS-5505, breaking down the fibrotic tissue around pancreatic cancer cells. Credit: Ella MaruFindings from the Garvan Institute of Medical Res

Updated on:February 20,2024

Adding vaccine to immunotherapy for liver cancer shows promise in early trial

by Dennis ThompsonClinical response. Credit:Nature Medicine(2024). DOI: 10.1038/s41591-024-02894-yA custom-made anti-tumor vaccine added to standard immunotherapy was twice as likely to sh

Updated on: April 28,2024

Adding vaccine to immunotherapy for liver cancer shows promise in early trial

by Dennis ThompsonClinical response. Credit:Nature Medicine(2024). DOI: 10.1038/s41591-024-02894-yA custom-made anti-tumor vaccine added to standard immunotherapy was twice as likely to sh

Updated on:April 28,2024

New leukemia drug is more effective and easier to use

by Loyola University Health SystemA Wright's stained bone marrow aspirate smear from a patient with precursor B-cell acute lymphoblastic leukemia. Credit: VashiDonsk/WikipediaA landmark study

Updated on: March 12,2024

New leukemia drug is more effective and easier to use

by Loyola University Health SystemA Wright's stained bone marrow aspirate smear from a patient with precursor B-cell acute lymphoblastic leukemia. Credit: VashiDonsk/WikipediaA landmark study

Updated on:March 12,2024